Trial intelligence / Profile preview

LiveSpo® Smile CARE for Dental Caries in Children

NCT07241052Recruiting

Sponsor
AnaBio Technologies
Start
Mar 2026
Primary completion
Oct 2026
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised, double-blind trial of LiveSpo Smile CARE in dental caries (2 arms), sponsored by AnaBio Technologies. Primary endpoint: Decayed Teeth Index at 3 months. Started Mar 2026; status: recruiting.

02

Drugs

LiveSpo Smile CARE
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT07241052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07241052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call